1. Johnson, MR, McBride, PE, Tsai, EJ, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary. Circulation. 2013;128(16):1810-1852. doi:10.1161/cir.0b013e31829e8807
Google Scholar | Crossref | Medline2. O’Connell, JB . The economic burden of heart failure. Clin Cardiol. 2009;23(3 suppl):III6-III10. doi:10.2165/00128413-199409570-00010
Google Scholar3. Dharmarajan, K, Rich, MW. Epidemiology, pathophysiology, and prognosis of heart failure in older adults. Heart Fail Clin. 2017;13(3):417-426. doi:10.1016/j.hfc.2017.02.001
Google Scholar | Crossref | Medline4. Vasan, RS, Benjamin, EJ, Levy, D, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347(18):1397-1402. doi:10.1056/nejmoa020265
Google Scholar | Crossref | Medline5. Cunha, GJL, Rocha, BML, Menezes Falcão, L. Iron deficiency in chronic and acute heart failure: a contemporary review on intertwined conditions. Eur J Intern Med. 2018;52:1-7. doi:10.1016/j.ejim.2018.04.013
Google Scholar | Crossref | Medline6. Jankowska, EA, Kasztura, M, Sokolski, M, et al. Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure. Eur Heart J. 2014;35(36):2468-2476. doi:10.1093/eurheartj/ehu235
Google Scholar | Crossref | Medline7. González-Costello, J, Comín-Colet, J. Iron deficiency and anaemia in heart failure: understanding the FAIR-HF trial. Eur J Heart Fail. 2010;12(11):1159-1162. doi:10.1093/eurjhf/hfq165
Google Scholar | Crossref | Medline8. van Veldhuisen, DJ, Anker, SD, Ponikowski, P, MacDougall, IC. Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches. Nat Rev Cardiol. 2011;8(9):485-493. doi:10.1038/nrcardio.2011.77
Google Scholar | Crossref | Medline | ISI9. Anker, SD, Dickstein, K, Ponikowski, P, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361(25):2436-2448. doi:10.1056/nejmoa0908355
Google Scholar | Crossref | Medline | ISI10. Ponikowski, P, van Veldhuisen, DJ, Comin-Colet, J, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J. 2015;36(11):657-668. doi:10.1093/eurheartj/ehu385
Google Scholar | Crossref | Medline11. Jankowska, EA, Tkaczyszyn, M, Suchocki, T, et al. Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials. Eur J Heart Fail. 2016;18(7):786-795. doi:10.1002/ejhf.473
Google Scholar | Crossref | Medline12. Ponikowski, P, Voors, AA, Anker, SD, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2021;0:1-128. doi:10.1093/euroheartj/ehab368
Google Scholar13. Ponikowski, P, Kirwan, BA, Anker, SD, et al. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet. 2020;396(10266):1895-1904. doi:10.1016/S0140-6736(20)32339-4
Google Scholar | Crossref | Medline14. Eche, IM, Owen, KL, Eche, IJ, Patel, P, Sabe, M. Safety and effectiveness of an accelerated intravenous iron administration protocol in hospitalized patients with heart failure. J Cardiovasc Pharmacol Ther. 2021;26(4):365-370. doi:10.1177/1074248421989871
Google Scholar | SAGE Journals | ISI15. Cappellini, MD, Comin-Colet, J, de Francisco, A, et al. Iron deficiency across chronic inflammatory conditions: international expert opinion on definition, diagnosis, and management. Am J Hematol. 2017;92(10):1068-1078. doi:10.1002/ajh.24820
Google Scholar | Crossref | Medline16. Macdougall, IC . Intravenous iron therapy in patients with chronic kidney disease: recent evidence and future directions. Clin Kidney J. 2017;10(suppl 1):i16-i24. doi:10.1093/ckj/sfx043
Google Scholar | Crossref | Medline17. Gomollón, F, Gisbert, JP. Intravenous iron in inflammatory bowel diseases. Curr Opin Gastroenterol. 2013;29(2):201-207. doi:10.1097/MOG.0b013e32835bdc2e
Google Scholar | Crossref | Medline18. Reiner Benaim, A, Almog, R, Gorelik, Y, et al. Analyzing medical research results based on synthetic data and their relation to real data results: systematic comparison from five observational studies. JMIR Med Informatics. 2020;8(2):e16492. doi:10.2196/16492
Google Scholar | Crossref | Medline19. Beck-Da-Silva, L, Piardi, D, Soder, S, et al. IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. Int J Cardiol. 2013;168(4):3439-3442. doi:10.1016/j.ijcard.2013.04.181
Google Scholar | Crossref | Medline20. Lewis, GD, Malhotra, R, Hernandez, AF, et al. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial. JAMA—J Am Med Assoc. 2017;317(19):1958-1966. doi:10.1001/jama.2017.5427
Google Scholar | Crossref | Medline21. Chetty, R, Stepner, M, Abraham, S, et al. The association between income and life expectancy in the United States, 2001-2014. JAMA—J Am Med Assoc. 2016;315(16):1750-1766. doi:10.1001/jama.2016.4226.27
Google Scholar | Crossref | Medline | ISI22. McEwan, P, Ponikowski, P, Davis, JA, et al. Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost-effectiveness analysis utilising AFFIRM-AHF. Eur J Heart Fail. Published online June 30, 2021. doi:10.1002/ejhf.2270
Google Scholar23. Coyne, DW, Kapoian, T, Suki, W, et al. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the dialysis patients’ response to IV iron with elevated ferritin (DRIVE) study. J Am Soc Nephrol. 2007;18(3):975-984. doi:10.1681/ASN.2006091034
Google Scholar | Crossref | Medline | ISI24. Wysowski, DK, Swartz, L, Borders-Hemphill, BV, Goulding, MR, Dormitzer, C. Use of parenteral iron products and serious anaphylactic-type reactions. Am J Hematol. 2010;85(9):650-654. doi:10.1002/ajh.21794.29
Google Scholar | Crossref | Medline25. Brookhart, MA, Freburger, JK, Ellis, AR, Winkelmayer, WC, Wang, L, Kshirsagar, AV. Comparative short-term safety of sodium ferric gluconate versus iron sucrose in hemodialysis patients. Am J Kidney Dis. 2016;67(1):119-127. doi:10.1053/j.ajkd.2015.07.026
Google Scholar | Crossref | Medline26. Okonko, DO, Grzeslo, A, Witkowski, T, et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency. FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol. 2008;51(2):103-112. doi:10.1016/j.jacc.2007.09.036
Google Scholar | Crossref | Medline27. Mamas, MA, Caldwell, JC, Chacko, S, Garratt, CJ, Fath-Ordoubadi, F, Neyses, L. A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure. Eur J Heart Fail. 2009;11(7):676-683. doi:10.1093/eurjhf/hfp085
Google Scholar | Crossref | Medline | ISI28. Gorenek, B, Halvorsen, S, Kudaiberdieva, G, et al. Atrial fibrillation in acute heart failure: a position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology. Eur Hear J Acute Cardiovasc Care. 2020;9(4):348-357. doi:10.1177/2048872619894255
Google Scholar | SAGE Journals29. Tedeschi, A, Agostoni, P, Pezzuto, B, et al. Role of comorbidities in heart failure prognosis part 2: chronic kidney disease, elevated serum uric acid. Eur J Prev Cardiol. 2020;27(2_suppl):35-45. doi:10.1177/2047487320957793
Google Scholar | SAGE Journals | ISI30. Vedin, O, Lam, CSP, Koh, AS, et al. Significance of ischemic heart disease in patients with heart failure and preserved, midrange, and reduced ejection fraction: a nationwide cohort study. Circ Heart Fail. 2017;10(6):e003875. doi:10.1161/CIRCHEARTFAILURE.117.003875
Google Scholar | Crossref | Medline31. Purek, L, Laule-Kilian, K, Christ, A, et al. Coronary artery disease and outcome in acute congestive heart failure. Heart. 2006;92(5):598-602. doi:10.1136/hrt.2005.066464
Google Scholar | Crossref | Medline